May 10th 2024
While Moderna expects mRNA-1345 to be approved later this month, the company cites FDA administrative constraints as reason for delay.
April 30th 2024
Your daily dose of the clinical news you may have missed.
April 22nd 2024
Researchers found that the COVID-19 booster dose elicited a 71%-84% increase in the median anti-spike half-life over that of the primary series.
March 29th 2024
Investigators found vaccine uptake of 41% among unvaccinated individuals who were part of a messaging intervention in the emergency department.
March 19th 2024
The novel 21-valent pneumococcal vaccine remains on track for the FDA PDUFA date of June 17, 2024; Merck adds this new data to the body of positive evidence.
Self-Administered Flu Vaccine May be “Powerful Tool” in Immunization Efforts, Says Expert
Ravi Jhaveri, MD, provides an overview of AstraZeneca's FluMist Quadrivalent vaccine and discusses why it could help increase vaccination rates.
Would you Know Measles if You Saw It?
A case of measles is a very rare diagnosis in the 21st century, but as MMR vaccination rates fall, the cases climb. Would you recognize the signs & symptoms?
This is Measles If You've Never Seen It
Here, the 5 key signs and symptoms that characterize measles in the order of appearance.
Measles and the Collective American Memory: 3 Questions
Measles cases are edging up in the US again as MMR vaccination rates continue to decline. Have parents forgotten the Ohio outbreak of 2022? Have you? Find out, here.
Influenza Vaccines: 4 Questions on What to Order, Which to Use
Influenza continues to rage in some parts of the US; try these 4 quick questions on vaccines you may or may not have on hand.
Updated Monovalent COVID-19 Vaccines Effective Against Symptomatic Infection, Emerging Variants
The updated COVID-19 vaccines were approximately 54% effective against symptomatic SARS-CoV-2 infection, according to new data from the CDC.
Daily Dose: Vaccination Reduces Risk of Long COVID in Children
Vaccination Provides Moderate Protection against Long COVID in Children
Vaccination against SARS-CoV-2 was associated with reduced risk of long COVID for at least 12 months in children and adolescents in a new large retrospective study.
Practice Pearls for Discussing COVID-19 Vaccines with Patients
Drs Tina Q. Tan and Rodney Rohde share final thoughts on addressing patient and parent concerns with COVID-19 vaccines.
mRNA Technology in COVID-19 Vaccine Production
Experts comment on the significance of mRNA (messenger RNA) technology in developing COVID-19 vaccines, as well as vaccines against other viral infections.
Approaching Patient Education About COVID-19 Vaccination
Rodney Rohde, PhD, MS, SM(ASCP)CM, shares his approach to initiating conversations around COVID-19 vaccination to patients and family members, highlighting the safety of administering multiple vaccines at during 1 visit.
Efficacy of Latest COVID-19 Vaccines
Experts discuss the efficacy of the latest vaccines against currently circulating strains of COVID-19, commenting on how long immunity lasts from these vaccines.
The Need for Vaccination Against COVID-19
Drs Tina Q Tan and Rodney Rohde review the importance of vaccinating against COVID-19 to prevent long COVID, as well as highlight the current vaccination recommendations.
Daily Dose: Coadministration of RSV and Influenza Vaccines
Coadministration of RSV, Influenza Vaccines Found Safe and Effective in New Study
The coadministration of RSVpreF and seasonal influenza vaccine was found to generate robust immune responses in older adults, reported authors of new study.
Vaccination in America: Highs and Lows by State
Get a quick look at the 5 states ranking highest and lowest on metrics including flu vaccination, tetanus vaccination, HPV vaccination, and more.
ID Specialist Underscores Vital Role of Vaccination among Health Care Professionals this Flu Season at IDWeek 2023
Clinicians must remember the point of vaccines was not to prevent infection, but to decrease severity of illness, says infectious disease specialist Gopi Patel, MD.
ID Specialist to Colleagues: Don’t Pass Your Germs to Your Patients This Flu Season
Gopi Patel, MD, emphasizes the importance of promoting vaccination and infection prevention measures among fellow clinicians, as well as patients, this season.
Daily Dose: Meningococcal Vaccination Coverage Disparities in the US
IDWeek 2023: New Research Identifies Disparities in COVID-19 Vaccine Coverage Within a Large, Racially and Ethnically Diverse Population
IDWeek 2023. The study identified disparities in coverage related to age, race, ethnicity, household income, insurance status, and prior influenza vaccination.
IDWeek 2023: Seasonal Flu Vaccine Offers More Protection for Immunocompetent Adults than Immunocompromised Peers, but “Difference not Statistically Significant”
Researchers say findings demonstrate the capacity to use an existing influenza vaccine effectiveness network to study a large immunocompromised population.
Adolescents Prefer Combination Meningococcal Vaccine to Separate MenACWY and MenB Administration a New Study Finds
IDWeek 2023: Adolescents expressed a preference for a combination vaccine covering serogroups A, B, C, W, Y of invasive meningococcal disease, reported researchers.
US Meningococcal Vaccination Coverage Has Increased, but Disparities Persist, According to Data Presented at IDWeek 2023
Findings underscore the persistence of disparities in meningococcal vaccination coverage in the US, particularly for vaccination against serogroup B.
COVID-19 Monovalent Vaccines: An ACIP Recommendations Quiz
A 2-question quiz on the ACIP's recommendations on the new COVID-19 monovalent vaccines that provide protection from currently circulating strains.
Updated Novavax COVID-19 Vaccine Authorized by FDA to Protect Against Current Variants
The Novavax COVID-19 vaccine is refreshed with 2023-2024 formula targeting the XBB.1.5 strain.
ACIP Recommends Maternal RSV Vaccine to Protect Newborns
Members of the ACIP voted on Friday to recommend Pfizer’s maternal bivalent RSVpreF vaccine to protect newborns from severe RSV illness.
Daily Dose: COVID-19 Vaccination Decreases Symptoms of Long COVID
Your daily dose of clinical news you may have missed.
COVID-19 Vaccination May Decrease Symptoms of Long COVID, Report Mayo Clinic Researchers
Vaccination against SARS-CoV-2 may decrease the symptoms of post-COVID conditions, such as abdominal pain and weakness, according to new study.
New-Onset Inflammatory Rheumatic Diseases May be Triggered by SARS-CoV-2 Infection or COVID-19 Vaccines, According to Recent Data
Findings from a recent study show a broad spectrum of possible clinical manifestations of IRD following SARS-CoV-2 infection or COVID-19 vaccination.
Daily Dose: How COVID-19 Vaccination Can Reduce Severity, Mortality after SARS-CoV-2 Infection
A daily dose of clinical news on Patient Care you may have missed.